H.C. Wainwright Reiterates Buy Rating on Paratek Pharmaceuticals (PRTK), Cites Impressive Preclinical Results in MAC Lung Infections
Go back to H.C. Wainwright Reiterates Buy Rating on Paratek Pharmaceuticals (PRTK), Cites Impressive Preclinical Results in MAC Lung InfectionsProfile Technologies, Inc. (NASDAQ: PRTK) | Delayed: 2.23 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.23 | 52 Week High | $22.00 | |||
Open | $2.23 | 52 Week Low | $9.80 | |||
Day High | $2.23 | P/E | N/A | |||
Day Low | $2.23 | EPS | $-0.08 | |||
Volume | 7,000 |